Received Apr 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 4 | 3004409 | PO / MO |
Client took first dose 4/3 and had initial lip swelling and left cheek and GI upset which improved with ibuprofen. Second dose was taken on 4/4 (client aware was too soon) caused hives and rashes throughout upper body and throat swelling, Client went to urgent care on 4/3 and received care. Client is fully recovered.
n/a
n/a
n/a
n/a